The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women

John Christopher G. Gallagher, B. Lawrence Riggs, Christine M. Jerpbak, Claude D. Arnaud

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

Serum iPTH was measured in a large series of normal and osteoporotic women as a function of age, with radioimmunoassays using three antisera: GP-1M, which recognizes primarily a region within the 44-68 amino acid sequence of PTH; CH-12M, which appears to recognize primarily intact hormone; and CH-14M, which recognizes primarily a region within the 1-34 amino acid sequence of PTH. In normal women 20 to 90 years of age, serum iPTH increased significantly with age (p <0.001); the proportional increase was greater when measured with antiserum GP-1M (80%) than when measured with antiserum CH-12M (30%), which suggests that the increase in circulating carboxyl fragments of PTH was greater than the increase in circulating intact PTH. In 40 patients with postmenopausal osteoporosis, the mean value for serum iPTH assayed by antiserum GP-1M did not differ significantly from that for age-matched normal women; however, three osteoporotic patients had elevated values and thus appear to represent a separate population. When these subjects were excluded, mean serum iPTH assayed by antiserum GP-1M also was lower than normal (p <0.001). The mean value for serum iPTH was lower in osteoporotic patients than in normal subjects when assayed by either antiserum CH-12M (p <0.001) or antiserum CH-14M (p <0.001). Values for serum phosphate and renal tubular phosphate resorption, both indices of PTH function, were increased (p <0.005) in the osteoporotic subjects. Although creatinine clearance decreased with age in both normal and osteoporotic subjects, partial correlations with age held constant showed no relationship between creatinine clearance and serum iPTH. This suggests that a decrease in renal function was not the major factor accounting for the rise in serum iPTH with age. We conclude that serum iPTH increases with aging but that for any given age, it is either normal or low in patients with postmenopausal osteoporosis.

Original languageEnglish
Pages (from-to)373-385
Number of pages13
JournalThe Journal of Laboratory and Clinical Medicine
Volume95
Issue number3
StatePublished - 1980
Externally publishedYes

Fingerprint

Parathyroid Hormone
Immune Sera
Serum
Postmenopausal Osteoporosis
Creatinine
Phosphates
Amino Acid Sequence
Amino Acids
Kidney
Aging of materials
Hormones
Radioimmunoassay
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. / Gallagher, John Christopher G.; Riggs, B. Lawrence; Jerpbak, Christine M.; Arnaud, Claude D.

In: The Journal of Laboratory and Clinical Medicine, Vol. 95, No. 3, 1980, p. 373-385.

Research output: Contribution to journalArticle

@article{5e6910f668ef455697c9830db7d7a837,
title = "The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women",
abstract = "Serum iPTH was measured in a large series of normal and osteoporotic women as a function of age, with radioimmunoassays using three antisera: GP-1M, which recognizes primarily a region within the 44-68 amino acid sequence of PTH; CH-12M, which appears to recognize primarily intact hormone; and CH-14M, which recognizes primarily a region within the 1-34 amino acid sequence of PTH. In normal women 20 to 90 years of age, serum iPTH increased significantly with age (p <0.001); the proportional increase was greater when measured with antiserum GP-1M (80{\%}) than when measured with antiserum CH-12M (30{\%}), which suggests that the increase in circulating carboxyl fragments of PTH was greater than the increase in circulating intact PTH. In 40 patients with postmenopausal osteoporosis, the mean value for serum iPTH assayed by antiserum GP-1M did not differ significantly from that for age-matched normal women; however, three osteoporotic patients had elevated values and thus appear to represent a separate population. When these subjects were excluded, mean serum iPTH assayed by antiserum GP-1M also was lower than normal (p <0.001). The mean value for serum iPTH was lower in osteoporotic patients than in normal subjects when assayed by either antiserum CH-12M (p <0.001) or antiserum CH-14M (p <0.001). Values for serum phosphate and renal tubular phosphate resorption, both indices of PTH function, were increased (p <0.005) in the osteoporotic subjects. Although creatinine clearance decreased with age in both normal and osteoporotic subjects, partial correlations with age held constant showed no relationship between creatinine clearance and serum iPTH. This suggests that a decrease in renal function was not the major factor accounting for the rise in serum iPTH with age. We conclude that serum iPTH increases with aging but that for any given age, it is either normal or low in patients with postmenopausal osteoporosis.",
author = "Gallagher, {John Christopher G.} and Riggs, {B. Lawrence} and Jerpbak, {Christine M.} and Arnaud, {Claude D.}",
year = "1980",
language = "English",
volume = "95",
pages = "373--385",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women

AU - Gallagher, John Christopher G.

AU - Riggs, B. Lawrence

AU - Jerpbak, Christine M.

AU - Arnaud, Claude D.

PY - 1980

Y1 - 1980

N2 - Serum iPTH was measured in a large series of normal and osteoporotic women as a function of age, with radioimmunoassays using three antisera: GP-1M, which recognizes primarily a region within the 44-68 amino acid sequence of PTH; CH-12M, which appears to recognize primarily intact hormone; and CH-14M, which recognizes primarily a region within the 1-34 amino acid sequence of PTH. In normal women 20 to 90 years of age, serum iPTH increased significantly with age (p <0.001); the proportional increase was greater when measured with antiserum GP-1M (80%) than when measured with antiserum CH-12M (30%), which suggests that the increase in circulating carboxyl fragments of PTH was greater than the increase in circulating intact PTH. In 40 patients with postmenopausal osteoporosis, the mean value for serum iPTH assayed by antiserum GP-1M did not differ significantly from that for age-matched normal women; however, three osteoporotic patients had elevated values and thus appear to represent a separate population. When these subjects were excluded, mean serum iPTH assayed by antiserum GP-1M also was lower than normal (p <0.001). The mean value for serum iPTH was lower in osteoporotic patients than in normal subjects when assayed by either antiserum CH-12M (p <0.001) or antiserum CH-14M (p <0.001). Values for serum phosphate and renal tubular phosphate resorption, both indices of PTH function, were increased (p <0.005) in the osteoporotic subjects. Although creatinine clearance decreased with age in both normal and osteoporotic subjects, partial correlations with age held constant showed no relationship between creatinine clearance and serum iPTH. This suggests that a decrease in renal function was not the major factor accounting for the rise in serum iPTH with age. We conclude that serum iPTH increases with aging but that for any given age, it is either normal or low in patients with postmenopausal osteoporosis.

AB - Serum iPTH was measured in a large series of normal and osteoporotic women as a function of age, with radioimmunoassays using three antisera: GP-1M, which recognizes primarily a region within the 44-68 amino acid sequence of PTH; CH-12M, which appears to recognize primarily intact hormone; and CH-14M, which recognizes primarily a region within the 1-34 amino acid sequence of PTH. In normal women 20 to 90 years of age, serum iPTH increased significantly with age (p <0.001); the proportional increase was greater when measured with antiserum GP-1M (80%) than when measured with antiserum CH-12M (30%), which suggests that the increase in circulating carboxyl fragments of PTH was greater than the increase in circulating intact PTH. In 40 patients with postmenopausal osteoporosis, the mean value for serum iPTH assayed by antiserum GP-1M did not differ significantly from that for age-matched normal women; however, three osteoporotic patients had elevated values and thus appear to represent a separate population. When these subjects were excluded, mean serum iPTH assayed by antiserum GP-1M also was lower than normal (p <0.001). The mean value for serum iPTH was lower in osteoporotic patients than in normal subjects when assayed by either antiserum CH-12M (p <0.001) or antiserum CH-14M (p <0.001). Values for serum phosphate and renal tubular phosphate resorption, both indices of PTH function, were increased (p <0.005) in the osteoporotic subjects. Although creatinine clearance decreased with age in both normal and osteoporotic subjects, partial correlations with age held constant showed no relationship between creatinine clearance and serum iPTH. This suggests that a decrease in renal function was not the major factor accounting for the rise in serum iPTH with age. We conclude that serum iPTH increases with aging but that for any given age, it is either normal or low in patients with postmenopausal osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=0018831310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018831310&partnerID=8YFLogxK

M3 - Article

C2 - 7354241

AN - SCOPUS:0018831310

VL - 95

SP - 373

EP - 385

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 3

ER -